| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 02/10/1993 | EP0526540A1 Use of 5-ht 4? receptor antagonists in the treatment of arrythmias and stroke |
| 02/10/1993 | CN1068744A Asialoglycoprotein-conjugated medicinal agent |
| 02/10/1993 | CN1068738A Modulation and diagnosis of cytokine dysfunctions |
| 02/10/1993 | CN1068737A Antihypertensive composition |
| 02/09/1993 | CA1313500C Pharmaceutical compositions for the treatment of occlusive vascular diseases |
| 02/08/1993 | CA2075328A1 Method of treating or preventing mastitis in animals with involuting mammary glands by administering recombinant cytokines |
| 02/04/1993 | WO1993001824A1 Combination therapy using bioflavonoid compounds with anti-cancer drugs |
| 02/04/1993 | WO1993001818A1 Antimicrobial treatment methods and compositions |
| 02/04/1993 | WO1993001717A1 Modulation and diagnosis of cytokine dysfunctions |
| 02/04/1993 | CA2113614A1 Antimicrobial treatment methods and compositions |
| 02/04/1993 | CA2113573A1 Modulation and diagnosis of cytokine dysfunctions |
| 02/03/1993 | EP0525992A2 Cluster conjugates of drugs with antibodies |
| 02/03/1993 | EP0525475A2 A beta-blocker and carbachol containing antiglaucoma composition |
| 02/03/1993 | EP0525055A1 Improved iontophoretic administration of drugs |
| 02/03/1993 | CN1068570A Antiviral combinations |
| 02/02/1993 | USH1139 Combination of a calcium channel blocker and thromboxane A2 receptor antagonist or synthetase inhibitor and method for treating ischemia employing such combination |
| 02/02/1993 | US5183814 Selective oestrogen therapy for perimenopausal or postmenopausal conditions |
| 02/02/1993 | US5183665 Using antihistamine |
| 01/28/1993 | CA2092408A1 Radioprotection by calcium antagonists |
| 01/27/1993 | EP0524633A2 Pharmaceutical composition suitable for influencing the reticuloendothelial system |
| 01/27/1993 | EP0524512A2 Antihypertensive combinations |
| 01/27/1993 | EP0524283A1 Pharmaceutical product for treating viral diseases |
| 01/27/1993 | EP0409940A4 Methods and compositions for treatment of pathological hydrophobic interactions in biological fluids |
| 01/26/1993 | US5182102 Mixture of a miotic and a beta-blocker, reduction of aqueous humor formation and improved outflow of humor |
| 01/26/1993 | CA1313136C Cough/cold mixtures comprising non-sedating antihistamine drugs |
| 01/21/1993 | WO1993000932A1 Method of reversing local anesthesia and reagent system therefor |
| 01/21/1993 | WO1993000927A1 Cancer treatment |
| 01/21/1993 | WO1993000919A1 Compositions and methods for inhibiting leukocyte adhesion to cns myelin |
| 01/21/1993 | WO1993000893A1 Nitric oxide synthesis inhibitors for potentiating the action of pressor agents in certain hypotensive patients |
| 01/21/1993 | CA2111345A1 Nitric oxide synthesis inhibitors for potentiating the action of pressor agents in certain hypotensive patients |
| 01/13/1993 | EP0522226A1 Eyedrop solution for the treatment of ocular hypertension containing ketauserin |
| 01/13/1993 | CN1067921A Antibiotic compound |
| 01/13/1993 | CA2072726A1 Anti-glaucoma compositions |
| 01/12/1993 | US5178857 Combination of interferon-gamma and an anthelmintic |
| 01/11/1993 | CA2071137A1 Composition and method for revitalizing scar tissue |
| 01/10/1993 | CA2073396A1 Pharmaceutical agent for treatment of withdrawal symptons |
| 01/07/1993 | WO1993000431A1 Ctl4a receptor, fusion proteins containing it and uses thereof |
| 01/07/1993 | WO1993000114A1 Topical composition enhancing healing of herpes lesions |
| 01/07/1993 | WO1993000113A1 A composition for treating a soft tissue injury |
| 01/07/1993 | WO1993000100A2 Wound cleanser |
| 01/07/1993 | WO1993000092A1 Improved process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates |
| 01/07/1993 | WO1992019182A3 Method of attenuation of neointimal proliferation |
| 01/07/1993 | EP0521692A2 Inhibition of tumor cell metastasis potential and invasiveness by chemically-defined oligosaccharides, their derivatives, mimetics and antibodies directed to them |
| 01/07/1993 | EP0521225A1 Pharmaceutical preparation for treatment of periodontitis, containing clavulanic acid |
| 01/07/1993 | EP0521070A1 Aqueous suspension preparation for injection, method for producing the same and use thereof for producing pain relief. |
| 01/07/1993 | EP0390849B1 Methyl cellulose pharmaceutical composition |
| 01/07/1993 | DE4121483A1 New use of quisqualate receptor antagonists |
| 01/07/1993 | CA2580812A1 Ctla4 receptor, fusion proteins containing it and uses thereof |
| 01/07/1993 | CA2112123A1 Wound cleanser |
| 01/07/1993 | CA2111837A1 Topical composition enhancing healing of herpes lesions |
| 01/05/1993 | US5177064 Targeted drug delivery via phosphonate derivatives |
| 01/05/1993 | CA1312286C Pharmaceutical preparation containing metoprolol |
| 01/05/1993 | CA1312282C Pharmaceutical compound, containing local anaesthetic and/or central analgesic encapsulated in liposomes |
| 01/02/1993 | CA2072824A1 Cluster conjugates of drugs with antibodies |
| 12/30/1992 | EP0519925A1 Use of optically pure s(-) atenolol for the treatment of cardiovascular disorders |
| 12/29/1992 | US5175165 Antiviral combinations and compounds therefor |
| 12/29/1992 | US5174475 Sequential dosing of antifungal and antiinflammatory compositions |
| 12/29/1992 | CA1312013C Compositions and methods for treating gastrointestinal disorders |
| 12/29/1992 | CA1312012C Compositions and methods for treating gastrointestinal disorders |
| 12/23/1992 | WO1992022819A1 Diagnosis and treatment of arterial chlamydial granuloma |
| 12/23/1992 | WO1992022202A1 Thrombolytic and perfluorochemical treatment for myocardial infraction |
| 12/23/1992 | EP0519903A1 Drug containing activated protein C |
| 12/23/1992 | EP0518951A1 Phenyl butyl nitrone compositions for prevention of gastric ulceration |
| 12/23/1992 | EP0518943A1 Mercaptoacyl aminolactam endopeptidase inhibitors |
| 12/23/1992 | CN1067243A Methods for preparation and use of 1 alpha, 24 dihydroxy vitamin d2 |
| 12/20/1992 | WO1992022310A1 Asialoglycoprotein-conjugated medicinal agent |
| 12/20/1992 | CA2089881A1 Asialoglycoprotein-conjugated medicinal agent |
| 12/16/1992 | EP0518798A2 Compositions for use in the treatment of aphtous ulcers and other mucocutaneous disorders |
| 12/16/1992 | EP0517854A1 Mononuclear leukocyte directed endothelial adhesion molecule associated with atherosclerosis |
| 12/16/1992 | EP0517850A1 Compositions and methods of treatment of sympathetically maintained pain |
| 12/16/1992 | EP0517836A1 Method and product for promoting hair growth and treating skin conditions |
| 12/15/1992 | US5171745 Administering to the mammal a combination of at least one strotonin receptor with neurotransmitter enhancer; useful for parkinson's/alzheimer's diseases, mental retardation, myasthenia gravis and senile-dementia |
| 12/15/1992 | US5171665 Monoclonal antibody to novel antigen associated with human tumors |
| 12/15/1992 | US5171580 Orally-pharmaceutical preparations with colon selective delivery |
| 12/15/1992 | US5171577 Process for the preparation of foams which can be used in the cosmetics and pharmaceutical field and foams obtained by this process |
| 12/11/1992 | WO1992022299A2 Use of antiarrhythmic agents to lower cholesterol |
| 12/11/1992 | CA2089164A1 Use of antiarrhythmic agents to lower cholesterol |
| 12/10/1992 | WO1992021347A1 Improved euthanasia compositions |
| 12/10/1992 | WO1992019244A3 A method for treating infectious respiratory diseases |
| 12/09/1992 | EP0517347A1 New combinations for the treatment of Parkinsons disease, containing NMDA-antagonists |
| 12/09/1992 | EP0516795A1 Use of quisqualate-receptor antagonists for treating parkinson's disease |
| 12/09/1992 | CN1066781A Ophthalmic compositions comprising combinations of carbonic anhydrase inhibitor and beta-adrenergic antagonist |
| 12/08/1992 | WO1992021325A1 Oral composition based on an antibiotic material and clay |
| 12/08/1992 | CA2088983A1 Therapeutic composition for gastrointestinal system inflammations |
| 12/06/1992 | WO1992021330A1 Particulate vector having selective tropism, method of preparation and pharmaceutical composition |
| 12/06/1992 | CA2088910A1 Particulate vector with selective tropism, process for the preparation thereof and pharmaceutical composition |
| 12/06/1992 | CA2070494A1 Combination preparations for treatment of parkinson's disease |
| 12/05/1992 | CA2070149A1 Hmg-coa reductase inhibitors in the prevention of restenosis following coronary angloplasty |
| 12/02/1992 | EP0516252A2 Monocrystalline particles of iron-oxide for application in medical diagnosis and therapy |
| 12/02/1992 | EP0516194A2 Pharmaceutical compositions containing cationic surfactants |
| 11/26/1992 | WO1992020816A1 Determination of prodrugs metabolizable by the liver and therapeutic use thereof |
| 11/26/1992 | WO1992020804A1 Atp-dependent protease and use of inhibitors for same in the treatment of cachexia and muscle wasting |
| 11/26/1992 | WO1992020796A2 D-type cyclin and uses related thereto |
| 11/26/1992 | WO1992020344A1 Antiviral combinations containing nucleoside analogs |
| 11/26/1992 | WO1992020328A2 Improvements in benzodiazepine treatment by cholinesterase inhibitors |
| 11/26/1992 | WO1992020327A1 Treatment of fatigue syndrome with cholinesterase inhibitors |
| 11/26/1992 | DE4124168A1 Thromboxane A2 antagonists, esp. daltroban - used to prevent thrombosis caused by admin. of recombinant human erythropoietin |
| 11/26/1992 | CA2108880A1 Treatment of fatigue syndrome with cholinesterase inhibitors |
| 11/26/1992 | CA2103161A1 D-type cyclin and uses related thereto |
| 11/26/1992 | CA2103050A1 Determination of prodrugs metabolizable by the liver and therapeutic use thereof |